News record
Moderna Stock Doubles on Positive Melanoma Vaccine Trial Results
Evidence state
developing
A Moderna or Merck press release or clinical-trial registry update with Phase 3 melanoma vaccine results matching the headline, plus registered-outlet coverage that directly cites that document.
Receipts
- captured headline
Moderna Stock Doubles on Positive Melanoma Vaccine Trial Results
- screenshot timestamp
screenshot timestamp
This page is a source-linked record. It does not score a person, infer motive, or replace the preserved source material.